RNASE3 and allergic rhinitis: Finally, the quinoline Montelukast, approved for asthma and allergic rhinitis, decreases eosinophil cationic protein and IL-8 serum and sputum levels, as well as the sputum levels of myeloperoxidase, in CF patients [55].